Literature DB >> 6246007

Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.

N Yamamoto, N Mueller-Lantzsch, H zur Hausen.   

Abstract

The effect of an amino acid analogue, L-canavanine, on the synthesis of Epstein-Barr virus (EBV) antigens was investigated in lymphoblastoid cells. The analysis revealed that after infection of BJAB and NC-37 cells with P3HR-I EBV synthesis of early antigen (EA) was not affected by canavanine in concentrations up to 8.4 mM. The synthesis of EBV-determined nuclear antigen (EBNA) and of viral capsid antigen (VCA) was significantly inhibited at concentrations higher than 2.8 mM. Spontaneous induction of EA in P3HR-I cells was not affected by canavanine. On the other hand, EA induction by the tumor promoter TPA resulted in some viral antigen induction depending on the time period of TPA exposure. Pretreatment of the cells overnight with canavanine followed by washing and addition of the tumor promoter did not suppress EA induction by TPA. These data support the concept that EA induction by superinfection follows a different pathway from antigen induction by chemical inducers.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246007     DOI: 10.1002/ijc.2910250403

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Spotlight on ethnomedicine: usability of Sutherlandia frutescens in the treatment of diabetes.

Authors:  Charles Sia
Journal:  Rev Diabet Stud       Date:  2004-11-10

2.  Effect of the arginine analog canavanine on the synthesis of Epstein-Barr virus-induced proteins in superinfected Raji cells.

Authors:  G J Bayliss; H Wolf
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

3.  12-O-tetradecanoylphorbol 13-acetate-inducible proteins are synthesized at an increased rate in Bloom syndrome fibroblasts.

Authors:  U Mallick; H J Rahmsdorf; N Yamamoto; H Ponta; R D Wegner; P Herrlich
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.